Qualitative evaluation of adherence therapy in Parkinson’s disease: a multidirectional model

Qualitative evaluation of adherence therapy in Parkinson’s disease: a multidirectional model

David James Daley,1,2 Katherine Helen O’Leary Deane,3 Richard John Gray,4 Rebekah Hill,3 Phyo Kyaw Myint5 1Norwich Medical School, Faculty of Medicine and Health Sciences, University of East Anglia, Norwich Research Park, 2Norfolk and Norwich University Hospital NHS Foundation Trust, 3Sch...

Full description

Bibliographic Details
Main Authors:	Daley DJ, Deane KHO, Gray RJ, Hill R, Myint PK
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-07-01
Series:	Patient Preference and Adherence
Online Access:	http://www.dovepress.com/qualitative-evaluation-of-adherence-therapy-in-parkinsonrsquos-disease-peer-reviewed-article-PPA

Similar Items

Adjuvant therapies for Parkinson’s disease: critical evaluation of safinamide
by: Stocchi F, et al.
Published: (2016-02-01)

Multidirectional inhalation therapy of acute rhinosinusitis
by: S. V. Morozova, et al.
Published: (2019-04-01)

Validation study of the Parkinson’s Fatigue Scale in advanced Parkinson’s disease
by: Martinez-Martin P, et al.
Published: (2019-04-01)

Pain Assessment in Chinese Parkinson’s Disease Patients Using King’s Parkinson’s Disease Pain Scale
by: Gao L, et al.
Published: (2022-03-01)

Comparison of Half-Effective Concentration of Propofol in Patients with Parkinson’s Disease and Non-Parkinson’s Disease
by: Wang P, et al.
Published: (2023-02-01)

Impact of Infusion Therapies on Quality of Life in Advanced Parkinson’s Disease
by: Constantin VA, et al.
Published: (2023-09-01)

The Effect of Patients’ Psychological Contract with Pharmacists on Medication Adherence: A Qualitative Study
by: Gu Y, et al.
Published: (2023-03-01)

Patients’ beliefs about adherence to oral antidiabetic treatment: a qualitative study
by: Guénette L, et al.
Published: (2015-03-01)

The efficacy of a “cocktail therapy” on Parkinson’s disease with dementia
by: Zhang C, et al.
Published: (2019-06-01)

Patients&rsquo; and caregivers&rsquo; experiences of the impact of Parkinson&rsquo;s disease on health status
by: Horacio Chiong-Rivero, et al.
Published: (2011-03-01)

Evaluating the perceived visual complexity of multidirectional hill-shading
by: Nikolaos Tzelepis, et al.
Published: (2021-01-01)

Excessive Daytime Sleepiness in Parkinson’s Disease
by: Liu H, et al.
Published: (2022-09-01)

Neuropsychiatric symptoms in untreated Parkinson’s disease
by: Szatmari S, et al.
Published: (2017-03-01)

Sleep disorders in Parkinson&rsquo;s disease
by: Israt Jahan, et al.
Published: (2009-10-01)

Patients’ beliefs about adherence to oral antidiabetic treatment: a qualitative study [Corrigendum]
by: Guénette L, et al.
Published: (2017-10-01)

Systematic review of the prevalence and incidence of Parkinson’s disease in the People’s Republic of China
by: Zou YM, et al.
Published: (2015-06-01)

Cytological and cytometric analysis of oral mucosa in patients with Alzheimer’s and Parkinson’s disease
by: Kose Ozlece H, et al.
Published: (2018-07-01)

Oncologists’ perspectives on adherence/non-adherence to adjuvant endocrine therapy and management strategies in women with breast cancer
by: Eraso Y
Published: (2019-07-01)

Music Therapy for Gait and Speech Deficits in Parkinson’s Disease: A Mini-Review
by: Fan, Leon, et al.
Published: (2023)

Evaluating Opicapone as Add-on Treatment to Levodopa/DDCI in Patients with Parkinson’s Disease
by: Jost WH
Published: (2022-08-01)

Patients’ Preferences for Adjunctive Parkinson’s Disease Treatments: A Discrete-Choice Experiment
by: Serbin M, et al.
Published: (2023-09-01)

Impact of Supporting People with Advanced Parkinson’s Disease on Carer’s Quality of Life and Burden
by: Modugno N, et al.
Published: (2020-12-01)

Distribution of non-motor symptoms in idiopathic Parkinson’s disease and secondary Parkinsonism
by: Skogar O, et al.
Published: (2018-10-01)

Advances with microRNAs in Parkinson’s disease research
by: Ma L, et al.
Published: (2013-10-01)

Parkinson’s Disease Managing Reversible Neurodegeneration [Retraction]
by: Hinz M, et al.
Published: (2020-12-01)

Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia [Retraction]
by: Hinz M, et al.
Published: (2021-03-01)

Parkinson’s Disease-Associated Melanin Steal [Retraction]
by: Hinz M, et al.
Published: (2021-03-01)

Children’s Adherence to Antiretroviral Therapy and Associated Factors: Multicenter Cross-Sectional Study
by: Gemechu GB, et al.
Published: (2023-07-01)

Adherence to antidepressant medications: an evaluation of community pharmacists’ counseling practices [Corrigendum]
by: Chong WW, et al.
Published: (2013-10-01)

Spotlight on opicapone as an adjunct to levodopa in Parkinson’s disease: design, development and potential place in therapy
by: Annus Á, et al.
Published: (2017-01-01)

Pioglitazone - the forgotten drug with multidirectional action
by: Arkadiusz Aab, et al.
Published: (2023-04-01)

Unidirectionality or multidirectionality? Some issues on grammaticalization
by: Ataliba T. de Castilho
Published: (2004-11-01)

Multidirectional action verbs of the russian language
by: E S Polyakova (Pashkina)
Published: (2013-12-01)

Multidirectional instability of the shoulder – current concept
by: Kim Seung-Ho
Published: (2009-06-01)

Mechanisms of Vietnam's Multidirectional Foreign Policy
by: Nicholas Chapman PhD
Published: (2017-08-01)

Home Care Patients’ Experiences with Home Care Nurses’ Support in Medication Adherence
by: Dijkstra NE, et al.
Published: (2021-09-01)

COPD: understanding patients’ adherence to inhaled medications
by: Duarte-de-Araújo A, et al.
Published: (2018-09-01)

Ceruloplasmin and iron in Alzheimer&rsquo;s disease and Parkinson&rsquo;s disease: a synopsis of recent studies
by: Kristinsson J, et al.
Published: (2012-11-01)

Impact of Safinamide on Patient-Reported Outcomes in Parkinson’s Disease
by: Espinoza-Vinces C, et al.
Published: (2023-10-01)

Parkinson’s Disease-Associated Melanin Steal [Expression of Concern]
by: Hinz M, et al.
Published: (2020-04-01)